Literature DB >> 11311229

Histone deacetylase complexes: functional entities or molecular reservoirs.

S Khochbin1, H Y Kao.   

Abstract

Recent investigations have allowed the identification of an increasing number of distinct nuclear multi-component complexes containing several types of enzymatic activity. Many of the complexes containing histone deacetylases are believed to control transcription and chromatin remodeling. We suggest here that at least some of these abundant complexes are likely to be "molecular reservoirs" of dynamic composition that exchange factors with other less abundant and functional complexes, according to specific required activities.

Mesh:

Substances:

Year:  2001        PMID: 11311229     DOI: 10.1016/s0014-5793(01)02327-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases.

Authors:  M V Simonini; L M Camargo; E Dong; E Maloku; M Veldic; E Costa; A Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

2.  Insulin-like growth factor-I stimulates histone H3 and H4 acetylation in the brain in vivo.

Authors:  Liou Y Sun; A Joseph D'Ercole
Journal:  Endocrinology       Date:  2006-08-24       Impact factor: 4.736

3.  Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways.

Authors:  D Seigneurin-Berny; A Verdel; S Curtet; C Lemercier; J Garin; S Rousseaux; S Khochbin
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.

Authors:  Gerda Lagger; Angelika Doetzlhofer; Bernd Schuettengruber; Eva Haidweger; Elisabeth Simboeck; Julia Tischler; Susanna Chiocca; Guntram Suske; Hans Rotheneder; Erhard Wintersberger; Christian Seiser
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

5.  Quantitative methods to analyze subnuclear protein organization in cell populations with varying degrees of protein expression.

Authors:  Ty C Voss; Ignacio A Demarco; Cynthia F Booker; Richard N Day
Journal:  J Biomed Opt       Date:  2005 Mar-Apr       Impact factor: 3.170

Review 6.  Emerging roles of epigenetic mechanisms in Parkinson's disease.

Authors:  Ehsan Habibi; Ali Masoudi-Nejad; Hamid Mostafavi Abdolmaleky; Stephen J Haggarty
Journal:  Funct Integr Genomics       Date:  2011-09-04       Impact factor: 3.410

7.  Autoregulation of mouse histone deacetylase 1 expression.

Authors:  Bernd Schuettengruber; Elisabeth Simboeck; Harald Khier; Christian Seiser
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis.

Authors:  Arunan S Vamadevan; Masayuki Fukata; Elizabeth T Arnold; Lisa S Thomas; David Hsu; Maria T Abreu
Journal:  Innate Immun       Date:  2009-08-26       Impact factor: 2.680

9.  Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control.

Authors:  Srividya Bhaskara; Brenda J Chyla; Joseph M Amann; Sarah K Knutson; David Cortez; Zu-Wen Sun; Scott W Hiebert
Journal:  Mol Cell       Date:  2008-04-11       Impact factor: 17.970

10.  Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.

Authors:  Vincent Quivy; Emmanuelle Adam; Yves Collette; Dominique Demonte; Alain Chariot; Caroline Vanhulle; Ben Berkhout; Rémy Castellano; Yvan de Launoit; Arsène Burny; Jacques Piette; Vincent Bours; Carine Van Lint
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.